Gnaphalium

Gnaphalium (Cudweed): A Comprehensive Reference

1. Identity: Botanical Classification, Names, and Natural Sources

Gnaphalium L. is a genus of flowering plants in the family Asteraceae, commonly called cudweeds or (formerly) chafeweeds. The genus, a herb distributed worldwide, comprises approximately 200 species of the Compositae (Asteraceae) family that belongs to the tribe Gnaphalieae. They are widespread and common in temperate regions, although some are found on tropical mountains or in the subtropical regions of the world.

The genus name derives from the Greek gnaphallon, meaning "tuft of wool," referring to the nature of the flower heads. The genus Gnaphalium (family Asteraceae) contains approximately 200 species scattered throughout the world, including China, Mexico, Argentina, North Korea, Philippines, Indonesia, India, and Australia.

1.1 Taxonomy and Key Species

The type species, designated by Linnaeus, is Gnaphalium uliginosum L., a small annual weed of moist soils. Phylogenetic studies based on nuclear and chloroplast markers reveal that the traditional circumscription of Gnaphalium is polyphyletic, with distinct clades corresponding to the genera Pseudognaphalium, Omalotheca, and some Helichrysum lineages. Consequently, a number of species have been transferred, and subgeneric delimitations remain unsettled; alternative treatments maintain a broad Gnaphalium concept pending further resolution.

The most medically and scientifically prominent species include:

• Gnaphalium affine D. Don — the most widely distributed and extensively utilized species, with the whole plant used for medicinal purposes. G. affine has a long history of use in traditional medicine and is known by various vernacular names, including "Qingmingcai."
• Gnaphalium uliginosum L. — a member of the Compositae, also known as Marsh cudweed, an annual plant widely used in Russian phytotherapy.
• Gnaphalium pensylvanicum Willd. — a species used in China as a folk medicine to treat anti-inflammatory conditions, cough, and rheumatism arthritis.
• Gnaphalium stramineum — a Central-American herbaceous plant commonly known as "sanalotodo," used in traditional medicine as an anti-inflammatory and anti-rheumatic agent.
• Pseudognaphalium obtusifolium (formerly Gnaphalium obtusifolium) — a member of the Asteraceae, found on open dry sandy habitat throughout eastern North America, with common names including old field balsam, rabbit tobacco, sweet everlasting, and life everlasting.

A notable nomenclatural complication arises in Mexico and Latin America, where multiple species belonging to Gnaphalium, Pseudognaphalium, and even unrelated Senecio species are all commonly sold under the name "gordolobo." In diverse regions of Mexico, various species belonging to the botanical genera Gnaphalium, Pseudognaphalium, and Senecio are commonly known as "gordolobo." Additionally, an entirely different plant from Europe, Verbascum thapsus (Scrophulariaceae), was the original medicinal plant that the Spanish brought to Mexico under the name "gordolobo."

1.2 Morphology

Plants in the genus are typically herbaceous annuals or perennials covered in characteristic woolly hairs. The leaves are gray-green and covered in a layer of fine, white, woolly hairs that give them a soft, velvety texture. These leaves are usually arranged alternately on the stem and form a basal rosette at the base, coming in shapes ranging from oblanceolate to spatulate, measuring 1 to 3 inches long and less than an inch wide. More than 200 species have been identified worldwide, of which 19 are distributed in China, mainly in regions south of the Yangtze River.

1.3 Common Preparations and Dosage Forms

Traditional and contemporary preparations of Gnaphalium species employ primarily the aerial parts — stems, leaves, and flowers. Forms documented across cultures include:

• Decoctions and infusions (teas): The most widespread preparation. Decoctions and infusions of the aerial parts of G. uliginosum are known to possess anti-inflammatory, astringent, and antiseptic properties.
• Poultices: Some Gnaphalium species are used in poultices to tend wounds, as a hemostatic, to fight infections, or ease inflammation.
• Food ingredient / vegetable: The aerial parts of G. affine are available in the cool season from November to January and are used as a flavor ingredient in foods for carminative purposes during Chinese New Year celebrations. Besides the nutritional value, G. affine is used in traditional Chinese medicine for resolving phlegm, relieving cough, and dispelling wind-cold syndrome.
• Topical washes: Decoctions are also applied topically as washes to treat various skin problems.
• Standardized tea preparations: There are also traditional Chinese medicine preparations with G. affine as tea on the market, which are mainly used for the treatment of hyperuricemia and gout.

Regarding dosage, one documented traditional guideline for decocting dried plant material suggests boiling 1 to 2 grams of dried plant material in a cup of water. The Russian phytotherapy tradition recommends internal administration at the dose of 1/2–1/3 of a glass of the infusion (10 g in 200 mL of water), 2–3 times per day for anti-inflammatory and hypotensive use. These dosages derive from traditional use reports, not controlled clinical trials.

---

2. Traditional and Historical Use

2.1 East Asia

G. affine has an edible history in China going back thousands of years. As early as the Jin Dynasty, G. affine had been used together with glutinous rice to make cakes for human consumption. The Japanese also used it for cooking porridge, and gradually people found that G. affine has certain pharmacological effects. Some species are not only used as a food source but have also been used for the treatment of various diseases including pain, rheumatism, chronic pharyngitis, and arthritis in China since ancient times.

G. affine is used in traditional Chinese medicine for resolving phlegm, relieving cough, and dispelling wind-cold syndrome. Gnaphalium affine D. Don, a medicinal and edible plant, has been used to treat gout in traditional Chinese medicine and has been popularly consumed in China for a long time. Several species have also been used for the treatment of various diseases including pain, rheumatism, chronic pharyngitis, and arthritis in China since ancient times.

2.2 Latin America and Mexico

Some species of the genus Gnaphalium, commonly known as "gordolobo," are used as folk medicine in Mexico to treat various respiratory diseases such as grippe, fever, asthma, cough, cold, bronchitis, expectorating, and bronchial affections. In some Latin American countries, plants belonging to the genus Gnaphalium are traditionally used for the relief of stomach diseases, swelling, wounds, prostatism, lumbago, neuritis, and angina ache, for the lowering of blood pressure, or as diuretic, antipyretic, and antimalarial.

In the Andean regions of South America, the hot beverage obtained by decoction of G. purpureum and G. elegans is recommended in folk contexts for the treatment of cancer. G. affine has also been used as a traditional medicine for the relief of swelling, wounds, lumbago, and angina ache in some Latin American countries.

2.3 Russian and Eastern European Traditions

Gnaphalium uliginosum L. (syn. Filaginella uliginosa (L.) Opiz), also known as Marsh cudweed, is an annual plant widely used in Russian phytotherapy. In Russian and Bulgarian phytotherapy, this plant is used in the treatment of hypertension and ulcers. Some information is available regarding the application of marsh cudweed for the treatment of thrombophlebitis and phlebothrombosis. In modern (Russian) medicine, this plant is recommended as an expectorant for bronchitis, neurosis, and stomach and intestinal ulcers, in combination with Gnaphalium uliginosum L. Varlakov first studied this plant in 1932 in connection with the medicinal flora of Eastern Sayan and proposed its use as an expectorant to replace imported Polygala senega L.

Traditional medical practitioners residing in the Balkan peninsula, Southeast Europe, use the aerial parts of G. uliginosum for the treatment of hypertension and ulcers.

2.4 Native American Traditions

Pseudognaphalium obtusifolium (L.) (= Gnaphalium obtusifolium L.) is an important plant used in the practice of traditional medicine among many Native American groups in eastern North America, including documented use among the Yuchi, an American Indian people from the Southeast.

2.5 European Folk Medicine

G. pellitum is used as an ornamental plant and applied to reduce swelling in German folk medicine. The inflorescence of G. sylvaticum is used in Polish folk medicine as a diuretic and vermifuge. The leaves of G. luteo-album are used as astringent, cholagogue, diuretic, febrifuge, and haemostatic.

2.6 Africa

Species such as Gnaphalium rubriflorum have been documented in ethnobotanical surveys of southern Ethiopia, where they are harvested during the rainy season and stored for use in the dry season.

---

3. Phytochemistry: Key Constituents and Active Compounds

More than 125 chemical constituents have been isolated from the genus Gnaphalium, including flavonoids, sesquiterpenes, diterpenes, triterpenes, phytosterols, anthraquinones, caffeoylquinic acid derivatives, and other compounds. The structures of 68 flavonoids, two sesquiterpenes, 28 diterpenes, five triterpenes, four phytosterols, two anthraquinones, five caffeoylquinic acid derivatives, and 10 other compounds have been catalogued across species.

3.1 Flavonoids

A wide range of flavonoids has been isolated from G. affine, each exhibiting distinct pharmacological activities such as antioxidant, anti-inflammatory, antibacterial, antitumor, and glucose-regulating effects. Based on chemical structure, they are classified into four major categories: flavones (1–23), flavonols (24–64), dihydroflavonoids (65–67), and chalcones (68–74), with flavonols being the most abundant.

Key individual flavonoids include luteolin-4′-O-glucoside (and its aglycone luteolin), quercetin and its glycosides, and apigenin-7-O-glucopyranoside, isorhamnetin-7-O-glucopyranoside, and scutellarein-7-O-glucoside. The bioactivities of G. affine are primarily attributed to flavonoids, polyphenols, and dicaffeoylquinic acids, and its unique chemical profile, particularly the presence of compounds such as Gnaphalin and 4,4′,6′-trihydroxy-2′-methoxychalcone, distinguishes it from other Gnaphalium species. Quercetin has been identified as a major active antioxidant component in G. affine extract.

3.2 Terpenoids

Terpenoids are a diverse class of natural compounds with multiple biological activities, including significant anti-inflammatory and antioxidant effects. Composed of isoprenoid (C5H8) units, they are biosynthesized through various pathways. G. affine contains a wide spectrum of terpenoids, among which triterpenoids are particularly prominent. Sesquiterpenes and monoterpenes are also commonly present, forming key components of the plant's volatile oils.

3.3 Caffeoylquinic Acid Derivatives

A detailed phytochemical investigation of the aerial part of G. affine led to the isolation of two new esters of caffeoylquinic acid named (–) ethyl 1,4-di-O-caffeoylquinate and (–) methyl 1,4-di-O-caffeoylquinate, together with 35 known compounds. In G. pensylvanicum, 13 caffeoylquinic acid derivatives and 1 flavone were identified by UPLC-ESI-MS/MS as the main active components.

3.4 Alkaloids and Other Compounds

Alkaloids are nitrogen-containing organic compounds that display diverse pharmacological activities, including neuroinhibitory, muscle relaxant, antimicrobial, and antitumor effects. Seven alkaloid compounds have been isolated from G. affine. Additional bioactive constituents identified in G. affine include Gnaphaffine A, Gnaphaffine B, Tithoniamide B, and 4′-hydroxydehydrokawain.

3.5 Phenolic Compounds in G. uliginosum

The chemical composition of G. uliginosum has been analyzed, revealing various biologically active substances such as flavonoids, alkaloids, tannins, polyphenols, coumarins, terpenoids, phytoestrogens, and carotenoids.

3.6 Unique Caffeoyl-Glucaric Acid Derivatives

Two unique caffeoyl-D-glucaric acid derivatives, leontopodic acid and leontopodic acid B, formerly only known from Leontopodium alpinum (L.) Cass., were detected in various species of Gnaphalium together with similar formerly unknown compounds. Gnaphalium is closely related to Leontopodium and both genera are assigned to the Gnaphaliinae subtribe (Asteraceae, Gnaphalieae). In all investigated Gnaphalium species — G. hoppeanum, G. norvergicum, G. supinum, G. sylvaticum, and G. uliginosum — both leontopodic acid and leontopodic acid B were detected.

---

4. Mechanisms of Action

4.1 Anti-Inflammatory Signaling

Studies have investigated the anti-inflammatory effect of G. affine methanol extract in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophage cells, fractionating the extract by measuring the generation of nitric oxide (NO). G. affine inhibited the generation of NO and prostaglandin E2. The chloroform-soluble fraction most effectively inhibited LPS-stimulated NO production. Results from related cell-line studies suggest that the anti-inflammatory effect of methanol fractions is associated with the suppression of NO production and iNOS expression through the down-regulation of NF-κB activation and MAPK signaling pathway in LPS-stimulated RAW264.7 macrophages.

4.2 Xanthine Oxidase Inhibition (Uric Acid Reduction)

All isolated compounds from G. affine were tested for their xanthine oxidase inhibitory activity with an in vitro enzyme inhibitory screening assay. Among the tested compounds, (–) ethyl 1,4-di-O-caffeoylquinate (IC₅₀ 11.94 μmol·L⁻¹) and (–) methyl 1,4-di-O-caffeoylquinate (IC₅₀ 15.04 μmol·L⁻¹) showed good inhibitory activity. Xanthine oxidase is the key enzyme responsible for uric acid biosynthesis, and its inhibition is the established pharmacological target of allopurinol, the first-line pharmaceutical treatment for gout.

4.3 Renal Urate Transporter Modulation

G. pensylvanicum extract showed activity in reducing serum uric acid through effects on renal glucose transporter 9 (GLUT9), organic anion transporter 1 (OAT1), and urate transporter 1 (URAT1) mainly, and inhibited XO activity in vivo in mice with potassium oxonate-induced hyperuricemia.

4.4 Antioxidant Mechanisms

In vitro assays demonstrate that G. affine extract shows remarkable antioxidant activity to scavenge free radicals (ABTS, DPPH, superoxide, and hydroxyl radicals), inhibit lipid peroxidation, and show reducing power. G. affine was found to be rich in phenolic substances, with the total phenolic content ranging from 14.62 to 59.30 mg GAE/g DW, which exhibited high antioxidant potential. The antioxidant activities showed a strong positive correlation with the total phenolic content (r > 0.9).

4.5 Complement System Modulation

Several Gnaphalium flavonoids have been evaluated for anti-complementary activity. Compounds isolated from G. affine, including novel phenolic glycosides named Gnaphaffine A and B, were evaluated for their anti-complementary activity on the classical pathway of the complement system in vitro. Anti-complementary activity refers to inhibition of the complement cascade, a component of innate immunity that, when dysregulated, contributes to inflammatory tissue damage.

4.6 Hypotensive Mechanism

The hypotensive effect of marsh cudweed is associated with a decrease in systolic blood pressure due to a decrease in cardiac output and the inhibition of baroreceptor sensitivity.

---

5. Scientific Evidence by Area of Use

Important caveat: No clinical data beyond single historical case reports have been found for most applications of Gnaphalium species. The quality control of the genus Gnaphalium is still based on local standards, and a national standard is required for genus Gnaphalium in China to validate its bioactivity and enable future clinical trials rigorously. The scientific evidence base consists predominantly of in vitro cell studies and animal models; controlled human clinical trials are lacking.

5.1 Respiratory Conditions (Cough, Asthma, Expectorant)

Traditional evidence: This is the most consistently documented traditional application across multiple cultures. Several species have long been used for treating asthma, cough, phlegm, rheumatism, and other disorders.

Scientific evidence: The extracts of this genus have been demonstrated to possess antitussive and expectorant properties among other pharmacological activities. G. affine exhibits traditional effects such as antitussive and expectorant activities, as recognized in the ethnopharmacological literature. However, the specific mechanisms underlying antitussive and expectorant effects have not been fully characterized in published English-language studies, and no human clinical trials were identified. The evidence remains primarily ethnobotanical with limited in vitro or animal-model pharmacological validation.

5.2 Anti-Inflammatory Activity

Scientific evidence (in vivo and in vitro): Anti-inflammatory activity is the most studied pharmacological property. G. affine D. Don has been, for centuries, prescribed for a variety of disorders including anti-inflammatory, antitussive, and expectorant activities in many Asian countries. G. affine D. Don has been traditionally used in China to manage various anti-inflammatory conditions. Evidence shows that pretreatment with G. affine D. Don extract attenuates inflammatory responses in vivo as well as in vitro, confirming the anti-inflammatory activity of G. affine D. Don. Mechanistic studies conducted in cell lines and carrageenan-induced rodent models demonstrate inhibition of the NF-κB and MAPK pathways, suppression of NO, prostaglandin E2, and iNOS expression. Evidence strength: preclinical (in vitro and animal). No human clinical trials identified.

5.3 Hyperuricemia and Gout

Scientific evidence (animal models): This is the area with the most mechanistically detailed recent research. The aim of one study was to evaluate the potential of the extract of G. pensylvanicum to treat hyperuricemia and acute gouty arthritis in an animal model. The extract was evaluated in an experimental model with potassium oxonate (PO)-induced hyperuricemia in mice, used to evaluate anti-hyperuricemia activity and xanthine oxidase (XO) inhibition. Therapies for acute gouty arthritis were also investigated on monosodium urate (MSU) crystal-induced paw edema models.

The extract showed activity in reducing serum uric acid through effects on renal urate transporters and inhibited XO activity in vivo. The extract also showed significant anti-inflammatory activity and reduced paw swelling in the MSU crystal-induced paw edema model. The extract of G. pensylvanicum showed significant effect on evaluated models and therefore may be active agents for the treatment of hyperuricemia and acute gouty arthritis.

Luteolin-4′-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models (published in Phytomedicine, 2018, Vol. 41, pp. 54–61).

A study by Zhang et al. (2017) published in the Journal of Ethnopharmacology investigated the effects of Gnaphalium affine D. Don on hyperuricemia and acute gouty arthritis (J Ethnopharmacol 203:304–311). Evidence strength: animal models only. No human clinical trials have been reported.

5.4 Antimicrobial Activity

Scientific evidence (in vitro): A 2024 study evaluated the antibacterial and antifungal effects of ethanol extracts from Gnaphalium uliginosum L. derived from freshly harvested plant biomass including stems, leaves, flowers, and roots. The extract was analyzed using gas chromatography-mass spectrometry (GC-MS) to determine its antimicrobial activity against phytopathogenic bacteria and fungi, using agar well diffusion and double serial dilution methods.

The 70% ethanol extract obtained through ultrasonic extraction had the highest antimicrobial activity compared to maceration. The most sensitive components were the Gram-positive phytopathogenic bacteria Clavibacter michiganensis and the Gram-negative phytopathogenic bacteria Erwinia carotovora spp., with MIC values of 156 μg/mL. Among the fungi, the most sensitive were Rhizoctonia solani and Alternaria solani (MIC values in the range of 78–156 µg/mL). These findings suggest that G. uliginosum has potential as a source of biologically active compounds for agricultural use, particularly for developing novel biopesticides. Evidence strength: in vitro only; primarily tested against phytopathogens rather than human pathogens.

5.5 Antioxidant Activity

Scientific evidence (in vitro): Liquid chromatography with electrochemical detection was utilized to separate the antioxidant compounds of G. affine, in conjunction with liquid chromatography-triple quadrupole mass spectrometry for identification. The in vitro antioxidant activity of G. affine was evaluated using DPPH and ABTS radical scavenging capacity assays, as well as the ferric reducing antioxidant power assay. The results showed that a total of 25 antioxidant compounds were screened and identified, among which 14 compounds were quantitatively analyzed. G. affine extract could inhibit the H₂O₂-induced oxidative injury in Caco-2 cells. Evidence strength: in vitro only.

5.6 Hepatoprotective Effects

Scientific evidence (animal models): G. affine extract exhibited antioxidant activity against oxidative liver damage and a hepatoprotective effect on CCl₄-induced liver injury in mice. G. affine has been observed to possess a protective effect against carbon tetrachloride-induced acute liver injury. Evidence strength: animal models only.

5.7 Antidiabetic and Metabolic Effects

Scientific evidence (animal models): Studies of the chloroformic extract of Gnaphalium sp. (CEG) in a model of alloxan-induced diabetes in Wistar rats were conducted. Gordolobo (Gnaphalium sp.) is a Mexican medicinal plant studied for the treatment of diabetes. Sesquiterpene lactones, polyphenolic compounds, triterpenes and steroids, apigenin, and lauric and myristic acid were identified in CEG by phytochemical, HPLC, and GC-MS analysis, and the antioxidant capacity evaluated by FRAP, DPPH, and ABTS inhibited the formation of free radicals. Compounds from G. affine exhibit pharmacological activities including regulation of lipid and glucose metabolism. Evidence strength: animal models only. No human clinical trials identified.

5.8 Cardiovascular / Hypotensive Effects

Historical clinical report: An original method for the treatment of patients with peptic ulcers involving the combined administration of infusions of Polemonium caeruleum and G. uliginosum has been reported (Panchenkov, 1950). The safety and efficacy of G. uliginosum have been confirmed during its long history of use; however, publications regarding its chemistry, pharmacological effects, and safety remain fragmentary. Evidence strength: a single historical case report from 1950; no modern randomized controlled trials identified.

5.9 Anticomplement Activity

Previous phytochemical investigations on Gnaphalium affine have reported the isolation of flavonoids, phenolic constituents, polysaccharides, essential oil compounds, diterpenes, and other chemical constituents. Many of these components have been demonstrated to possess anti-complementary and antifeedant activities. Anti-complementary activity in the complement system's classical pathway has been documented in in vitro assays with isolated G. affine phenolic glycosides. Evidence strength: in vitro only.

5.10 Antitumor Activity

Numerous studies have elucidated the pharmacological properties of G. affine and its bioactive constituents. This plant exhibits diverse therapeutic effects, including antibacterial, antimicrobial, anti-inflammatory, antioxidant, anticomplement, hepatoprotective, and anticancer activities, and inhibition of xanthine oxidase. Compounds from G. affine exhibit pharmacological activities including anti-tumor activities. These cytotoxic and anticancer observations derive entirely from in vitro cell-line work. Evidence strength: in vitro only. No animal or human evidence identified.

---

6. Body Systems and Health Areas

The pharmacological effects of Gnaphalium are mainly manifested in pulmonary protection, antimicrobial activity, anti-inflammatory and anti-complementary activities, antioxidant activity, antidiabetic effect, anti-hyperuricemia and gout effect, and others. Based on the consolidated scientific and traditional literature, the body systems and health areas associated with Gnaphalium include:

• Respiratory system: Antitussive and expectorant uses; treatment of cough, bronchitis, asthma, phlegm, and cold syndromes.
• Musculoskeletal / metabolic system: Hyperuricemia, gout, and rheumatism, primarily via xanthine oxidase inhibition and renal urate transporter modulation.
• Immune system: Complement system inhibition (anti-complementary activity); anti-inflammatory effects on NF-κB and MAPK pathways.
• Cardiovascular system: Hypotensive effects documented in Russian phytotherapy tradition; the hypotensive effect of marsh cudweed is associated with a decrease in systolic blood pressure due to a decrease in cardiac output and the inhibition of baroreceptor sensitivity.
• Gastrointestinal system: Treatment of peptic ulcers and stomach ailments in Russian and Bulgarian traditions; carminative use in Chinese food culture.
• Hepatobiliary system: Hepatoprotective effects observed in animal models of chemical liver injury.
• Vascular system: Historical use for thrombophlebitis and phlebothrombosis in Russian phytotherapy.
• Integumentary system: Wound-healing, hemostatic, and antiseptic topical applications across multiple cultures.
• Endocrine/metabolic system: Antidiabetic effects studied in animal models; regulation of lipid and glucose metabolism.

---

7. Notable Safety Considerations and Interactions

7.1 General Safety Status

Gnaphalium affine is a plant with various active properties and has been approved for use as a traditional medicine and food ingredient in China, reflecting a long established history of culinary consumption. The safety and efficacy of G. uliginosum have been confirmed during its long history of use; however, publications regarding its chemistry, pharmacological effects, and safety remain fragmentary.

7.2 Asteraceae/Compositae Hypersensitivity

As a member of the Asteraceae family, Gnaphalium shares the class-level hypersensitivity risk documented across this plant family. Asteraceae plants can elicit both immediate and delayed hypersensitivity reactions; for instance, exposure to plant material may cause an IgE-mediated type 1 hypersensitivity reaction or a type IV hypersensitivity reaction manifesting as airborne allergic contact dermatitis. The main contact allergens present in Asteraceae plants are sesquiterpene lactones, which are found in the leaves, stems, flowers, and pollen. The most abundant allergens present in the Asteraceae family are sesquiterpene lactones (SLs), which are found in flowers, stems, leaves, and even pollen.

Asteraceae-related allergy symptoms involve eczema, hay fever, asthma, or even anaphylaxis. Individuals with known sensitivity to other members of the Asteraceae family — such as chamomile, chrysanthemum, ragweed, or arnica — may be at elevated risk of cross-reactive responses when using Gnaphalium preparations.

7.3 Quality Control and Adulteration Concerns

The toxicity of each species of Gnaphalium should be comprehensively evaluated, including heavy metals and contamination with pesticide residues, to provide a scientific basis for safe use as both drug and food. At present, there is no unified national quality standard for the genus Gnaphalium, and most are based on local standards. Moreover, only TLC or HPLC methods were used in some local standards, which might not reflect the comprehensive quality of Gnaphalium.

The "gordolobo" naming confusion in Mexico and Latin America presents a documented adulteration risk. In diverse regions of Mexico, various species belonging to the botanical genera Gnaphalium, Pseudognaphalium, and Senecio are all commonly known as "gordolobo." The genus Senecio contains pyrrolizidine alkaloids known for hepatotoxicity, making species-level identification of commercial "gordolobo" products a meaningful safety concern. The absence of a unified pharmacopoeial standard compounds this risk.

7.4 Evidence Gaps

Research concerning the chemical composition, biological activities, and potential applications of G. affine remains limited. No large-scale toxicological studies, safety pharmacology studies, drug-interaction data, or reproductive/developmental safety data were identified in the peer-reviewed literature for any species within this genus. The quality control of the genus Gnaphalium is still based on local standards, and a national standard is required for Gnaphalium in China to validate its bioactivity and enable future clinical trials rigorously.

---

8. Current State of Evidence and Research Gaps

Analysis of findings from major databases shows that plants in the genus Gnaphalium have demonstrated potential in various therapeutic uses, including pulmonary protection, antimicrobial activity, antioxidant activity, anti-inflammatory and anti-complementary activities, and antidiabetic effect. However, the overwhelming majority of this evidence derives from in vitro cell-culture assays or rodent model experiments. The dual role of G. affine as both a traditional herbal medicine and a dietary resource highlights its potential for functional food and nutraceutical development, as well as its relevance in disease prevention and health promotion.

Critical gaps preventing definitive clinical conclusions include: (1) the absence of randomized controlled human trials for any indication; (2) incomplete standardization of extracts used across different studies; (3) reliance on animal models that may not translate directly to human physiology; (4) insufficient long-term safety data; and (5) the complex taxonomy that makes cross-species comparison of results difficult. The quality control of the genus Gnaphalium is still based on local standards, and a national standard is required for the genus to validate its bioactivity and enable future clinical trials rigorously.

References

• Zheng X, Wang W, Piao H, et al. "The Genus Gnaphalium L. (Compositae): Phytochemical and Pharmacological Characteristics." Molecules. 2013;18(7):8298–8318. PMC6270383.
• Wang X, Liu D, Xiong L, et al. "Ethnopharmacology, phytochemistry, bioactivities and quality control of the Gnaphalium genus: an updated review." Medicinal Plant Biology. 2024;3:e005.
• PMC13074846. "Chemical Compositions, Traditional Applications, and Biological Activities of Gnaphalium affine D. Don: A Comprehensive Review." PMC 2025.
• PMC9774822. "Assessment of Gnaphalium viscosum (Kunth) Valorization Prospects: Sustainable Recovery of Antioxidants by Different Techniques." PMC 2022.
• Davydova L, Menshova A, Shumatbaev G, et al. "Phytochemical Study of Ethanol Extract of Gnaphalium uliginosum L. and Evaluation of Its Antimicrobial Activity." Antibiotics (Basel). 2024;13(8):785. PMC11352081.
• PMC5474058. "Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model."
• PubMed 27324043. "The Anti-inflammatory Effect of Gnaphalium affine Through Inhibition of NF-κB and MAPK in Lipopolysaccharide-Stimulated RAW264.7 Cells and Analysis of Its Phytochemical Components."
• PubMed 29860995. "Chemical constituents from Gnaphalium affine and their xanthine oxidase inhibitory activity."
• Huang D, Chen Y, et al. "Anti-inflammatory effects of the extract of Gnaphalium affine D. Don in vivo and in vitro." Journal of Ethnopharmacology. 2015;176:356–364.
• Zeng X et al. "The antioxidant activity and active component of Gnaphalium affine extract." Food and Chemical Toxicology. 2013.
• "Profiling, identification, and quantification of antioxidant components in Gnaphalium affine by HPLC-ECD-MS/MS." International Journal of Food Properties. 2024;27(1).
• PMC6270502. "Two New Phenolic Glycosides from Gnaphalium affine D. Don and Their Anti-Complementary Activity."
• ScienceDirect Topics. "Gnaphalium — an overview." (Covers G. uliginosum in Russian/Bulgarian phytotherapy.)
• Luckert J. "Spirit Medicine: Native American Uses of Common Everlasting (Pseudognaphalium obtusifolium) in Eastern North America." Indiana University ScholarWorks.
• Wikipedia. "Gnaphalium." (For leontopodic acid distribution and taxonomy.)
• PMC6428906. "Asteraceae species as potential environmental factors of allergy." Environmental Science and Pollution Research. 2019.
• MDedge/Cutis. "Asteraceae Dermatitis: Everyday Plants With Allergenic Potential."
• Ključevšek et al. "Allergic Potential of Medicinal Plants From the Asteraceae Family." Health Science Reports. 2025.
• PlantaeDB. "Gnaphalium L. (genus) — species list & taxonomy."